Low dose Vasopressin in Septic Shock

Robert Docking, Kevin Rooney, Chris Cairns

Research output: Contribution to journalArticlepeer-review


The addition of low-dose vasopressin to the treatment of septic shock does not reduce mortality compared to the use of norepinephrine alone, but allows a rapid reduction in norepinephrine requirements.Level of evidence: 1+ (RCT with a very low risk of bias)
Original languageEnglish
Pages (from-to)262-263
Number of pages2
JournalJournal of the Intensive Care Society
Issue number3
Publication statusPublished - 2008


Dive into the research topics of 'Low dose Vasopressin in Septic Shock'. Together they form a unique fingerprint.

Cite this